Drug recall D-1117-2022
Product
Cefazolin for injection USP, and Dextrose Injection, USP, 1G, 50 ML duplex container, Rx only, MFG: B. Braun Medical Inc., NDC 0264-3103-11
Reason for recall
cGMP deviations: Temperature abuse
Lots and codes
McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.
Recall details
- Recalling firm
- Mckesson Medical-Surgical Inc. Corporate Office, Richmond, VA
- Quantity
- 26 cases
- Distribution
- USA nationwide.
- Type
- Voluntary: Firm initiated
- Recall initiated
- April 13, 2022
- Terminated
- November 30, 2023
Related products
- Cefazolin Sodium – drug information
- NDC 0264-3107 Cefazolin Sodium · Cefazolin Sodium 3 g/50mL · B. Braun Medical Inc.
- NDC 0264-3105 Cefazolin Sodium · Cefazolin Sodium 2 g/50mL · B. Braun Medical Inc.
- NDC 0264-3103 Cefazolin Sodium · Cefazolin Sodium 1 g/50mL · B. Braun Medical Inc.